Patent directory · USPTO A61K / A61P
Patents matching “Fate Therapeutics, Inc.”
40 pharma patents match "Fate Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 40 pharmaceutical patents matching "Fate Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12419870
Compositions and methods for immune cell modulation in adoptive immunotherapies
granted -
US 12410403
Methods and compositions for inducing hematopoietic cell differentiation
granted -
US 12398373
Enhanced immune effector cells and use thereof
granted -
US 12385012
Methods and compositions for inducing hematopoietic cell differentiation
granted -
US 12281329
Compositions and methods for immune cell modulation in adoptive immunotherapies
granted -
US 12275955
Combining iPSC derived effector cell types for immunotherapy use
granted -
US 12264322
Minimal volume reprogramming of mononuclear cells
granted -
US 12247226
Cellular reprogramming using temporal and transient plasmid vector expression system
granted -
US 12203098
Cells having solid tumor targeting backbone and use thereof
granted -
US 12173274
Enhanced immune effector cells and use thereof
granted -
US 12122846
Chimeric antigen receptor for tumor targeting
granted -
US 12036241
Compositions and methods for immune cell modulation in adoptive immunotherapies
granted -
US 11932870
Compositions and methods for immune cell modulation in adoptive immunotherapies
granted -
US 11851677
Composition and methods for inducing myeloid suppressive cells and use thereof
granted -
US 11634688
Methods and compositions for inducing hematopoietic cell differentiation
granted -
US 11413309
Compositions and methods for immune cell modulation in adoptive immunotherapies
granted -
US 11365394
Enhanced immune effector cells and use thereof
granted -
US 11352607
Genomic engineering of pluripotent cells
granted -
US 11162075
Methods and compositions for inducing hematopoietic cell differentiation
granted -
US 11162076
Methods and compositions for inducing hematopoietic cell differentiation
granted -
US 11135244
Stem cell culture media and methods of enhancing cell survival
granted -
US 11096964
Compositions and methods for immune cell modulation in adoptive immunotherapies
granted -
US 11072781
Genomic engineering of pluripotent cells
granted -
US 11052118
Enhanced stem cell composition
granted